acut
respiratori
ill
ari
lead
caus
morbid
across
demograph
socioeconom
strata
worldwid
primari
trigger
exacerb
chronic
lower
airway
diseas
includ
asthma
gene
express
pattern
character
peak
ari
symptom
well
describ
understand
molecular
event
resolut
ari
remain
limit
moreov
remain
determin
presenc
underli
allerg
respiratori
diseas
asthma
influenc
molecular
event
cours
ari
peak
resolut
symptom
transcript
profil
studi
reveal
pathophysiolog
phenotyp
therapeut
respons
asthma
accompani
distinct
gene
express
profil
howev
despit
account
highest
proport
asthmarel
healthcar
expenditur
littl
known
molecular
event
character
ari
environment
induc
exampl
pollen
dander
chemic
episod
exacerb
compar
profil
studi
exacerb
stabl
asthmat
baselin
reveal
asthma
exacerb
involv
complex
interact
acut
chronic
andor
allerg
state
inflamm
howev
contemporari
profil
studi
exacerb
often
exclud
nonasthmat
allerg
control
negat
mani
gene
express
pattern
identifi
particularli
episod
ariinduc
exacerb
genuin
exacerbationspecif
signatur
furthermor
despit
constitut
initi
barrier
exacerbationinduc
exposur
profil
studi
focus
airway
mucosa
exacerb
hinder
comprehens
understand
molecular
event
precipit
asthma
exacerb
address
defici
understand
molecular
event
character
ari
ariinduc
asthma
exacerb
undertook
transcript
profil
studi
nasal
mucosa
cours
ari
individu
asthma
allerg
rhiniti
underli
respiratori
diseas
report
ari
character
dynam
timespecif
transcript
profil
whose
magnitud
express
influenc
underli
respiratori
diseas
mucos
repair
signatur
evok
ari
strikingli
peopl
asthma
experi
ariinduc
exacerb
character
reduc
prolong
inflammatori
immun
respons
inadequ
activ
mucos
repair
express
newli
describ
exacerbationspecif
transcript
signatur
report
encompass
sampl
natur
acquir
upper
respiratori
ill
studi
conduct
univers
california
san
francisco
ucsf
novemb
novemb
studi
design
approv
ucsf
committe
human
research
studi
conform
helsinki
declar
written
inform
consent
obtain
particip
prior
inclus
studi
particip
histori
asthma
hay
fever
underli
airway
diseas
recruit
studi
via
commun
advertis
upon
onset
ari
common
cold
symptom
recruit
particip
instruct
attend
first
three
requir
visit
studi
clinic
first
second
visit
design
obtain
sampl
clinic
data
peak
reductionresolut
stage
symptomat
ill
wherea
third
visit
would
occur
volunt
asymptomat
serv
prospect
baselin
bl
studi
studi
popul
repres
attend
first
second
third
clinic
visit
averag
day
rang
day
day
rang
day
day
rang
day
onset
ari
symptom
visit
obtain
nasal
scrape
arlington
scientif
inc
springvil
ut
usa
lower
turbin
right
side
visit
one
left
visit
two
side
baselin
visit
two
nasal
lavag
ml
salin
remov
overli
mucu
also
measur
visit
exhal
nitric
oxid
eno
forc
expiratori
flow
second
perform
spirometri
bl
visit
particip
underw
methacholin
test
assess
airway
hyperreact
allergi
skin
test
determin
atop
particip
instruct
complet
diari
record
sever
common
cold
chest
asthma
symptom
peak
expiratori
flow
rate
pef
use
miniwright
meter
kwmed
inc
usa
twice
day
previous
describ
viru
identif
nasal
lavag
visit
one
perform
use
pcrbase
techniqu
previous
outlin
use
friedman
repeatedmeasur
rank
test
analyz
chang
across
three
time
point
mann
whitney
utest
comparison
group
correl
analyz
use
spearman
rank
correl
asthma
exacerb
ari
defin
priori
either
increas
asthma
symptom
made
particip
increas
start
inhal
oral
corticosteroid
seek
medic
care
doctor
offic
urgent
care
clinic
emerg
depart
increas
chest
asthma
symptom
score
point
day
averag
daili
score
baselin
week
plu
least
one
object
chang
use
puff
albuterol
averag
daili
use
baselin
week
day
declin
ari
first
second
visit
compar
bl
declin
pef
day
cold
week
compar
best
pef
achiev
bl
week
total
rna
extract
nasal
mucosa
sampl
use
rneasi
mini
kit
qiagen
valencia
ca
usa
addit
dnase
treatment
promega
madison
wi
usa
repurif
phase
extract
rna
purifi
use
rna
clean
concentr
zymo
research
irvin
ca
usa
qualiti
assess
rna
pico
kit
bioanalyz
agil
technolog
santa
clara
ca
usa
sampl
exhibit
high
rna
integr
ng
rna
submit
ucsf
share
microarray
core
facil
microarray
experi
employ
whole
human
genom
array
platform
agil
technolog
microarray
data
deposit
gene
express
omnibu
geo
small
group
number
limit
statist
power
groupbas
analys
time
pointbas
compar
analys
conduct
use
normal
gene
express
data
identifi
overal
tempor
transcript
profil
ari
exampl
versu
bl
analysi
varianc
linear
model
fit
comparison
estim
mean
express
valu
differenti
express
gene
identifi
calcul
moder
tstatist
b
statist
fals
discoveri
rate
raw
pvalu
comparison
interest
addit
mix
linear
model
fit
gene
estim
withinsubject
correl
singl
robust
averag
correl
use
withinsubject
correl
fit
linear
model
gene
adjust
pvalu
produc
method
propos
holm
encompass
complet
rang
gene
express
driven
ari
subsequ
analys
foldchang
cutoff
appli
signific
differenti
express
gene
identifi
adjust
p
procedur
carri
use
function
r
packag
limma
bioconductor
princip
compon
analysi
pca
use
identifi
primari
sourc
variat
drive
differenti
express
gene
identifi
time
pointbas
microarray
analysi
n
adjust
p
pca
perform
covari
matric
gene
express
data
repres
normal
probe
intens
n
gene
probessampl
use
past
initi
pca
includ
match
time
point
microarray
sampl
studi
group
encompass
potenti
sourc
variat
cours
studi
exampl
ari
diseas
statu
sex
medic
addit
groupbas
pca
encompass
three
time
point
transit
bl
bl
conduct
use
avail
microarray
sampl
group
statist
confirm
influenc
diseas
statu
ariinduc
chang
gene
express
found
pca
separ
time
point
cluster
along
princip
compon
axi
determin
analysi
score
sampl
pair
ttest
match
sampl
utest
unmatch
sampl
sinc
regard
repres
ariassoci
variat
within
dataset
determin
ariassoci
transcript
profil
rank
n
gene
base
load
gene
rank
gener
groupbas
bl
bl
pca
use
identifi
ariassoci
profil
character
peak
reduct
resolut
stage
group
respect
sinc
consist
compon
load
cutoff
could
found
within
literatur
top
n
posit
neg
load
gene
select
group
subject
compar
analys
total
use
venni
time
point
exhibit
posit
score
peak
reduct
resolut
n
posit
gene
highest
group
compar
time
point
exhibit
neg
score
reduct
n
neg
gene
lowest
group
compar
kinet
gene
express
determin
plot
gene
probe
intens
time
point
probe
intens
scale
maximum
intens
gene
across
time
point
studi
group
minimum
hierarch
cluster
analysi
microarray
data
fold
chang
express
perform
euclidean
distanc
averag
linkag
use
mev
correl
analysi
gene
express
load
conduct
determin
express
level
core
share
distinct
gene
defin
stage
ari
studi
group
correl
analys
perform
use
prism
window
graphpad
softwar
inc
la
jolla
ca
usa
gene
enrich
analysi
gea
perform
use
thomson
reuter
gene
enrich
profil
identifi
enrich
biolog
process
pathway
within
gene
set
use
gene
ontolog
latter
deriv
curat
databas
experiment
valid
interact
employ
hypergeometr
model
determin
signific
function
relationship
gene
enrich
profil
gener
enrich
analysi
gene
set
variou
cell
type
provid
celltissu
perspect
larg
gene
express
dataset
total
rna
particip
three
bl
two
either
combin
bl
match
sampl
select
quantit
realtim
pcr
analysi
miss
sampl
due
either
particip
fail
attend
one
three
clinic
visit
sampl
rna
quantiti
minim
gene
select
express
confirm
base
load
depend
stage
ari
analyz
highest
rank
peak
reduct
resolut
lowest
reduct
gene
select
gene
express
sampl
normal
dehydrogenas
peptidylprolyl
isomeras
outlin
previous
signific
fold
chang
gene
copi
number
group
determin
mann
whitney
utest
primer
probe
sequenc
avail
upon
request
summari
studi
design
depict
figur
briefli
adult
asthma
allerg
rhiniti
underli
respiratori
diseas
recruit
onset
common
cold
ari
symptom
visit
studi
clinic
nasal
mucosa
sampl
symptomat
ill
asymptomat
bl
sampl
taken
least
day
later
base
studi
data
clinic
histori
allergi
skin
test
methacholin
challeng
particip
categor
one
four
studi
group
healthi
underli
respiratori
diseas
allerg
rhiniti
allrg
rhin
asthmat
without
episod
exacerb
asm
noex
asthmat
episod
exacerb
studi
period
asm
ex
figur
addit
file
studi
group
experienc
signific
increas
nasal
symptom
bl
howev
sever
asthma
symptom
airway
obstruct
measur
peak
flow
highest
level
eno
observ
within
asm
ex
group
figur
respiratori
virus
detect
similar
rate
among
group
tabl
given
studi
group
experienc
complet
cours
ari
symptom
figur
sought
initi
identifi
tempor
transcript
profil
ari
figur
employ
microarray
sampl
figur
timepoint
base
microarray
analysi
versu
bl
versu
versu
bl
reveal
total
gene
exhibit
differenti
express
cours
studi
adjust
p
data
shown
pca
confirm
primari
sourc
variat
drive
differenti
express
princip
compon
timedepend
figur
addit
file
consid
ari
would
timedepend
biolog
phenomenon
consist
across
studi
group
reason
gene
defin
measur
compon
load
would
therefor
repres
transcript
profil
ari
groupbas
pca
indic
differenti
gene
express
character
transit
studi
time
point
influenc
diseas
statu
figur
addit
file
investig
underli
diseas
influenc
transcript
profil
ari
conduct
addit
groupbas
pca
encompass
peak
bl
reduct
resolut
bl
ari
symptom
figur
addit
file
compar
ariassoci
profil
studi
group
respect
figur
consist
dramat
increas
symptom
figur
analysi
groupbas
pca
indic
studi
group
exhibit
clear
transit
bl
figur
addit
file
sinc
studi
concentr
influenc
underli
respiratori
diseas
ari
asymptomat
baselin
identifi
focus
ariassoci
profil
time
point
studi
group
see
method
compar
analysi
ariassoci
profil
reveal
common
gene
indic
peak
stage
ari
character
core
transcript
profil
independ
underli
respiratori
diseas
figur
tabl
addit
file
gea
determin
gene
associ
proinflammatoryimmun
process
pathway
cell
tabl
addit
file
transit
toward
associ
predominantli
presenc
respiratori
viru
shown
analysi
viru
identif
figur
addit
file
microarray
express
data
show
robust
increas
gene
express
figur
result
indic
transcript
profil
peak
stage
reflect
activ
immun
respons
although
posit
express
gene
defin
peak
stage
studi
group
investig
indic
presenc
asthma
exacerb
influenc
magnitud
gene
express
figur
figur
addit
file
quantit
realtim
pcr
analysi
select
gene
express
microarray
addit
studi
sampl
figur
addit
file
subsequ
confirm
peak
stage
ari
asthma
exacerb
character
express
pattern
consist
reduc
activ
inflammatori
immun
respons
occur
regardless
presenc
absenc
medic
figur
e
compar
analysi
ariassoci
profil
respect
indic
gene
common
figur
tabl
addit
file
subsequ
compar
analysi
reveal
gene
share
gene
previous
identifi
peak
stage
data
shown
howev
vigor
neg
express
pattern
defin
time
point
amongst
healthi
allrg
rhin
asm
noex
group
asm
ex
group
exhibit
prolong
posit
express
gene
figur
figur
addit
file
quantit
realtim
pcr
analysi
select
gene
express
indic
reduct
stage
ari
asthmat
exacerb
character
express
pattern
consist
inadequ
modul
inflammatori
respons
occur
presenc
absenc
medic
figur
e
compar
analysi
ariassoci
profil
reveal
common
gene
exist
across
studi
group
rather
gene
share
amongst
healthi
allrg
rhin
asm
noex
group
asm
ex
group
character
almost
exclus
set
distinct
gene
figur
tabl
addit
file
focus
initi
ariassoci
gene
share
healthi
allrg
rhin
asm
noex
group
use
gea
determin
gene
associ
process
pathway
consist
mucos
repair
recruit
immun
cell
tabl
addit
file
howev
robust
express
repairassoci
gene
defin
time
point
amongst
healthi
allrg
rhin
asm
noex
group
asm
ex
group
exhibit
earlier
reduc
express
pattern
figur
figur
addit
file
quantit
realtim
pcr
analysi
subsequ
confirm
reduct
stage
ari
asthmat
exacerb
character
express
pattern
consist
inadequ
mucos
repair
presenc
absenc
medic
figur
e
focus
ariassoci
gene
asm
ex
group
figur
use
gea
determin
limit
number
gene
associ
known
biolog
process
pathway
cell
type
tabl
addit
file
kinet
gene
indic
overal
reduc
express
within
asm
ex
group
figur
investig
reveal
subset
gene
exhibit
asm
exspecif
pattern
express
figur
figur
addit
file
quantit
realtim
pcr
analysi
confirm
exacerbationspecif
express
transmembran
protein
tmem
occur
regardless
presenc
absenc
medic
figur
e
strikingli
chang
gene
express
found
associ
lower
airway
obstruct
exclus
within
asm
ex
group
figur
taken
togeth
result
indic
addit
inadequ
mucos
repair
reduct
stage
ari
asthma
exacerb
character
exacerbationspecif
profil
express
pattern
could
associ
clinic
manifest
exacerb
consist
declin
symptom
figur
groupbas
pca
indic
group
exhibit
clear
transit
bl
figur
addit
file
compar
analysi
ariassoci
gene
respect
bl
reveal
common
figur
tabl
addit
file
subsequ
compar
analysi
indic
gene
share
gene
previous
identifi
peak
stage
figur
indic
relat
bl
time
point
exhibit
inflammatoryassoci
profil
kinet
analysi
reveal
asm
ex
group
maintain
highest
express
gene
figur
c
remark
howev
investig
reveal
time
point
amongst
healthi
group
defin
limit
express
pattern
gene
figur
figur
addit
file
quantit
realtim
pcr
analysi
select
gene
confirm
healthi
group
exhibit
lowest
express
level
immuneassoci
gene
encod
fc
fragment
immunoglobulin
g
low
affin
iiia
aquaporin
heighten
express
cell
structureassoci
gene
encod
keratin
figur
taken
togeth
result
indic
resolut
stage
ari
absenc
underli
respiratori
diseas
result
quicker
resolut
inflamm
continu
activ
mucos
repair
address
defici
understand
mechan
character
ari
ariinduc
asthma
exacerb
undertook
transcript
profil
studi
nasal
mucosa
cours
ari
amongst
asthmat
allerg
nonasthmat
otherwis
healthi
control
employ
system
biolog
approach
identifi
first
time
transcript
profil
correspond
biolog
process
character
scope
ari
symptom
amongst
four
clinic
distinct
group
result
obtain
propos
ari
categor
three
stage
underli
respiratori
diseas
influenc
transcript
profil
andor
express
pattern
defin
stage
ari
figur
peak
stage
ari
defin
robust
express
proinflammatoryassoci
gene
coincid
greatest
sever
ari
symptom
figur
consist
previou
studi
respiratori
viru
infect
clinic
present
transcript
profil
express
pattern
identifi
studi
signifi
activ
immun
respons
howev
studi
reveal
first
time
height
ari
symptom
character
express
core
set
gene
regardless
presenc
underli
respiratori
diseas
figur
identif
core
transcript
profil
peak
stage
ari
expect
sinc
ari
frequent
viral
origin
immun
respons
nasal
mucosa
predominantli
innat
addit
common
cold
present
experienc
studi
particip
figur
would
also
suggest
molecular
event
orchestr
ari
conserv
therefor
imparti
presenc
underli
respiratori
diseas
remark
howev
observ
clinic
distinct
group
exhibit
specif
prefer
measur
load
express
level
core
gene
figur
figur
addit
file
indic
underli
respiratori
diseas
influenc
intens
natur
innat
immun
respons
airway
mucosa
promin
find
peak
stage
ari
asthmat
exacerb
exhibit
express
pattern
consist
reduc
activ
inflammatori
immun
respons
figur
although
find
bolster
previou
report
defici
innat
antivir
immun
respons
asthmat
particularli
episod
exacerb
express
pattern
identifi
could
also
reflect
use
asthma
medic
absenc
detect
viru
infect
exacerb
tabl
figur
addit
file
howev
observ
littl
effect
asthma
medic
inflammatori
gene
express
reduct
ari
symptom
eno
level
within
asm
ex
group
figur
suggest
either
presenc
inflammatori
cell
infiltr
tabl
addit
file
nonimmun
process
within
airway
mucosa
drive
ari
symptom
develop
exacerb
reduct
stage
repres
uniqu
period
ari
symptom
present
declin
figur
stage
differ
asthmat
experienc
exacerb
individu
ari
evid
figur
reduct
stage
ari
defin
transcript
profil
express
pattern
correspond
two
distinct
biolog
process
modul
inflammatori
immun
respons
figur
activ
mucos
repair
mechan
figur
although
like
intuit
studi
found
core
inflammatori
gene
character
peak
symptom
also
character
reduct
symptom
exhibit
neg
express
pattern
figur
importantli
identifi
transcript
profil
character
repair
mechan
nasal
mucosa
figur
e
found
addit
abil
modul
inflammatori
immun
respons
simultan
subsequ
initi
mucos
repair
cellular
divis
immun
cell
recruit
parallel
reduct
ari
symptom
figur
interestingli
transcript
profil
identifi
studi
highli
similar
found
lower
airway
mucosa
respons
mechan
injuri
indic
innat
repair
mechan
like
exist
throughout
entir
airway
result
studi
also
suggest
addit
target
select
proinflammatori
compon
exampl
cxcl
famili
member
augment
repair
mechan
within
nasal
mucosa
may
provid
therapeut
relief
ari
symptom
major
find
reduct
stage
ari
presenc
asthma
exacerb
dramat
influenc
inflammatori
respons
modul
mucos
repair
mechan
initi
asthmat
exacerb
character
sustain
asthma
symptom
high
level
eno
figur
blunt
express
pattern
gene
associ
mucos
repair
figur
despit
similar
proport
medic
use
asthmat
exacerb
versu
tabl
addit
highlight
ineffect
current
exacerb
treatment
find
suggest
defici
repair
respons
similar
observ
vitro
present
within
airway
epithelium
asthmat
exacerb
strike
find
reduct
stage
asthmat
ariinduc
exacerb
character
distinct
transcript
profil
within
nasal
mucosa
figur
remark
major
exacerbationspecif
gene
identifi
found
lack
associ
known
biolog
process
pathway
cell
type
tabl
addit
file
support
view
uncharacter
otherwis
neglect
mechan
nonimmuneinflammatori
contribut
develop
ariinduc
exacerb
identifi
subset
exacerb
gene
exhibit
exacerbationspecif
express
pattern
figur
chang
express
one
gene
occur
regardless
medic
use
associ
lower
airway
obstruct
figur
f
involv
mucu
product
airway
smooth
muscl
contract
suggest
express
tmem
famili
member
contribut
pathophysiolog
asthma
character
requir
consid
exacerb
gene
identifi
within
studi
repres
genuin
exacerb
signatur
potenti
target
exacerbationspecif
therapi
third
final
stage
ari
reflect
residu
activ
inflammatori
immun
respons
return
toward
asymptomat
baselin
figur
defin
posit
express
small
core
proinflammatori
gene
resolut
stage
ari
except
absenc
underli
respiratori
diseas
found
distinct
featur
find
studi
reveal
otherwis
healthi
individu
character
express
pattern
consist
reduc
proinflammatori
immun
respons
continu
mucos
repair
reflect
quicker
resolut
ari
absenc
underli
respiratori
diseas
figur
determin
transcript
profil
character
peak
resolut
ari
symptom
amongst
asthmat
allerg
nonasthmat
individu
otherwis
healthi
control
reveal
presenc
asthma
exacerb
dramat
influenc
molecular
event
character
ari
studi
indic
peopl
asthma
experienc
ariinduc
exacerb
character
reduc
prolong
inflammatori
immun
respons
inadequ
activ
mucos
repair
mechan
strikingli
distinct
set
gene
constitut
exacerbationspecif
transcript
signatur
although
absenc
correspond
cellular
composit
data
nasal
mucosa
exampl
via
flow
cytometri
focu
exclus
upper
airway
may
limit
studi
find
repres
signific
contribut
toward
clarifi
complex
molecular
interact
character
ariinduc
asthma
exacerb
allrg
rhin
patient
allerg
rhiniti
ari
acut
respiratori
ill
asm
ex
patient
asthma
exacerb
asm
noex
patient
asthma
without
exacerb
bl
baselin
ccl
chemokin
cc
motif
ligand
cxcl
chemokin
cxc
motif
ligand
day
day
eno
exhal
nitric
oxid
forc
expiratori
flow
second
gea
gene
enrich
analysi
ic
inhal
corticosteroid
ns
nasal
steroid
princip
compon
pca
princip
compon
analysi
pcr
polymeras
chain
reaction
pef
peak
expiratori
flow
rate
tmem
transmembran
protein
author
declar
compet
interest
pca
hab
conceiv
design
studi
tw
involv
studi
recruit
sampl
collect
sf
js
pm
asb
process
sampl
dje
anb
rb
ce
conduct
micorarray
experi
sb
conduct
princip
compon
analysi
pm
conduct
data
analysi
qpcr
experi
pm
sb
pca
rp
draft
manuscript
author
read
approv
final
manuscript
